A vs LFCR · P/E 29, rev $1.88B vs $207.1M cap
Agilent Technologies Inc (A) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
LFCR does not have a complete income-statement cache yet.
A currently screens at market cap $33.70B and trailing P/E 29.2. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the A and LFCR stock pages for the full models.
Not investment advice.